Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Bone cement study for revision joint surgery withdrawn before start

NCT ID NCT06699160

First seen Jan 03, 2026 · Last updated Jun 23, 2026 · Updated 24 times

Summary

This study was designed to check the safety and performance of Refobacin Revision-3 Bone Cement when used in hip or knee revision surgeries. It aimed to track how often metal implants needed to be removed, any side effects, and changes in pain, function, and quality of life. However, the study was withdrawn before any participants were enrolled, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REVISION ARTHROPLASTY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Diakonessenhuis UMC Utrecht

    Utrecht, 3582, Netherlands

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Refobacin Revision-3 Bone Cement

What this could lead to

If successful, this study could confirm that the cement is safe and effective for use in hip or knee revision surgeries.

What could go wrong

The study was withdrawn before enrolling any participants, so no data will be collected. This means we cannot draw any conclusions from it.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.